{"id":"NCT00121641","sponsor":"AstraZeneca","briefTitle":"Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-07","primaryCompletion":"2006-08","completion":"2010-02","firstPosted":"2005-07-21","resultsPosted":"2011-05-11","lastUpdate":"2015-04-03"},"enrollment":1035,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Saxagliptin","otherNames":["BMS-477118"]},{"type":"DRUG","name":"Saxagliptin","otherNames":["BMS-477118"]},{"type":"DRUG","name":"Saxagliptin","otherNames":["BMS-477118"]},{"type":"DRUG","name":"Placebo matching Saxagliptin","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Placebo matching Metformin","otherNames":[]},{"type":"DRUG","name":"Saxagliptin","otherNames":["BMS-477118"]},{"type":"DRUG","name":"Metformin","otherNames":[]}],"arms":[{"label":"Saxagliptin 2.5 mg (A)","type":"EXPERIMENTAL"},{"label":"Saxagliptin 5 mg (B)","type":"EXPERIMENTAL"},{"label":"Saxagliptin 10 mg (C)","type":"EXPERIMENTAL"},{"label":"Placebo (D)","type":"PLACEBO_COMPARATOR"},{"label":"Open-Label Treatment Cohort (Direct Enrollees) (E)","type":"EXPERIMENTAL"}],"summary":"The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise","primaryOutcome":{"measure":"Hemoglobin A1c (A1C) Changes From Baseline at Week 24","timeFrame":"Baseline, Week 24","effectByArm":[{"arm":"Saxagliptin 2.5 mg","deltaMin":7.91,"sd":0.09},{"arm":"Saxagliptin 5 mg","deltaMin":7.98,"sd":0.11},{"arm":"Saxagliptin 10 mg","deltaMin":7.85,"sd":0.09},{"arm":"Placebo","deltaMin":7.88,"sd":0.1}],"pValues":[{"comp":"OG000 vs OG003","p":"<.0001"},{"comp":"OG001 vs OG003","p":"<.0001"},{"comp":"OG002 vs OG003","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":134,"countries":["United States","Australia","Canada","Mexico","Puerto Rico","Taiwan"]},"refs":{"pmids":["19650754","29976228","27402391","27033025","23802840"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":66},"commonTop":["UPPER RESPIRATORY TRACT INFECTION","HEADACHE","NASOPHARYNGITIS","URINARY TRACT INFECTION","INFLUENZA"]}}